课题基金 / 基金详情

FOOD HYPERSENSITIVITY IN THE PATHOGENESIS OF ATOPIC DISORDERS

FOOD HYPERSENSITIVITY IN THE PATHOGENESIS OF ATOPIC DISORDERS
特应性疾病发病机制中的食物过敏
批准号:
5215573
负责人:
LARRY W WILLIAMS
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

LARRY W WILLIAMS的其他基金

相似基金

相关文献

中文摘要
翻译
食物过敏在特应性发病中的作用
英文摘要
The role of food hypersensitivity in the pathogenesis of atopic dermatitis (AD) and other atopic diseases has been debated for years. In the 1930s, Engman described a wheat-sensitive child who developed eczematoid skin changes following wheat ingestion, but only on areas unprotected by occlusive dressing, suggesting a role for food-induced pruritus and scratching in the development of the dermatitis. More recently studies have renewed interest in the role of food hypersensitivity in the pathogenesis of atopic dermatitis (AD) and other atopic disorders. However, questions with respect to disease definition, study design, and adequacy of controls left uncertain the importance of food in the pathogenesis of AD and other atopic diseases, such as asthma. The primary hypothesis is that food hypersensitivity reactions exhibit both immediate and late-phase components that may be recognized clinically (development of objective physical findings) and by detection of mediators characteristic of mast cells and basophils in the circulating blood. In patients having late-phase reactions additional cell types are involved and may be detected by elevation of serum eosinophil cationic protein and myeloperoxidase. A secondary hypothesis is that the late reactions (more than 12 hours after challenge) detected by other investigators are artefactual, possibly due to the open nature of the studies and the lack of objectivity of the measured outcomes. Thus, in patients undergoing a prolonged, double-blinded, placebo-controlled challenge study, no differences in symptom scores or behavioral observation scores will be detected between placebo weeks and active weeks.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
THE LEUKOTRIENE MODIFIER OR CORTICOSTEROID OR CORTICOSTEROID-SALMETEROL TRIAL (T
  • 批准号:
    7198481
  • 项目类别:
  • 资助金额:
    $7.32万
  • 财政年份:
    2005
  • 负责人:
    LARRY W WILLIAMS
  • 依托单位:
Low-Dose Theophylline as Add-on Therapy in Asthma
  • 批准号:
    6974049
  • 项目类别:
  • 资助金额:
    $0.17万
  • 财政年份:
    2004
  • 负责人:
    LARRY W WILLIAMS
  • 依托单位:
Leukotriene Modifier/Corticosteroid/Corticosteroid Trial
  • 批准号:
    6974051
  • 项目类别:
  • 资助金额:
    $3.38万
  • 财政年份:
    2004
  • 负责人:
    LARRY W WILLIAMS
  • 依托单位:
COCKROACH ALLERGEN CONTROL TECHNIQUES
  • 批准号:
    6534163
  • 项目类别:
  • 资助金额:
    $26.06万
  • 财政年份:
    2000
  • 负责人:
    LARRY W WILLIAMS
  • 依托单位:
海外基金